Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation

Biochemistry

Volumn 48, Issue 35, 2009, Pages 8466-8472

  Halili, Maria A ^a   Ruiz Gómez, Gloria ^a   Le, Giang T ^a   Abbenante, Giovanni ^a   Fairlie, David P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE CONDITIONS; CATALYTIC ACTIVITY; CATALYTIC PROPERTIES; CELL SURFACES; CLASSICAL PATHWAY; COFACTORS; CONFORMATIONAL CHANGE; DAMAGED CELLS; HOST CELLS; INFLAMMATORY DISEASE; INNATE IMMUNE RESPONSE; MEMBRANE ATTACK COMPLEXES; PEPTIDE FRAGMENTS; PEPTIDE SUBSTRATES; PROTEASE ACTIVITIES; SERINE PROTEASE; SHEEP ERYTHROCYTES; SMALL MOLECULE INHIBITOR;

AMINES; AMINO ACIDS; CONFORMATIONS; ENZYME ACTIVITY; PEPTIDES; PLASMA DIAGNOSTICS;

CELL MEMBRANES;

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4B; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME PRECURSOR; LECTIN; SERINE PROTEINASE;

ARTICLE; BACTERIOLYSIS; CATALYSIS; COMPLEMENT CLASSICAL PATHWAY; HEMOLYSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C2B; COMPLEMENT C3; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3B; COMPLEMENT C4B; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, CLASSICAL; ERYTHROCYTES; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN CONFORMATION; PROTEIN FOLDING; SERINE ENDOPEPTIDASES; SHEEP;

OVIS ARIES;

EID: 69749125540     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900679r     Document Type: Article

References (42)

1. Gasque, P. (2004) Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41, 1089-1098.
2. Sim, R. B., and Tsiftsoglou, S. A. (2004) Proteases of the complement system. Biochem. Soc. Trans. 32, 21-27.
3. Selander, B., Martensson, U., Weintraub, A., Holmstrom, E., Matsushita, M., Thiel, S., Jensenius, J. C., Truedsson, L., and Sjoholm, A. G. (2006) Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J. Clin. Invest. 116, 1425-1434.
4. Markiewski, M. M., and Lambris, J. D. (2007) The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171, 715-727.
5. DiScipio, R. G. (1982) The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology 45, 587-595. (Pubitemid 12165625)
6. Kirschfink, M., and Borsos, T. (1988) Binding and activation of C4 and C3 on the red cell surface by non-complement enzymes. Mol. Immunol. 25, 505-512.
7. Leung, D., Abbenante, G., and Fairlie, D. P. (2000) Protease inhibitors: current status and future prospects. J. Med. Chem. 43, 305-341.
8. Abbenante, G., and Fairlie, D. P. (2005) Protease inhibitors in the clinic. Med. Chem. 1, 71-104.
9. Furlong, S. T., Dutta, A. S., Coath, M. M., Gormley, J. J., Hubbs, S. J., Lloyd, D., Mauger, R. C., Strimpler, A. M., Sylvester, M. A., Scott, C. W., and Edwards, P. D. (2000) C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles. Immunopharmacology 48, 199-212. (Pubitemid 30608676)
10. Kerr, M. A. (1979) Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology. Biochem. J. 183, 615-622.
11. Bentley, D. R., and Porter, R. R. (1984) Isolation of cDNA clones for human complement component C2. Proc. Natl. Acad. Sci. U.S.A. 81, 1212-1215.
12. Bentley, D. R. (1986) Primary structure of human complement component C2. Homology to two unrelated protein families. Biochem. J. 239, 339-345.
13. Hourcade, D. E., Mitchell, L. M., and Oglesby, T. J. (1998) A conserved element in the serine protease domain of complement factor B. J. Biol. Chem. 273, 25996-26000.
14. Rawal, N., and Pangburn, M. K. (2003) Formation of high affinity C5 convertase of the classical pathway of complement. J. Biol. Chem. 278, 38476-38483.
15. Kerr, M. A. (1980) The human complement system: assembly of the classical pathway C3 convertase. Biochem. J. 189, 173-181.
16. Kam, C. M., McRae, B. J., Harper, J. W., Niemann, M. A., Volanakis, J. E., and Powers, J. C. (1987) Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates. J. Biol. Chem. 262, 3444-3451.
17. Cooper, N. R. (1975) Enzymatic activity of the second component of complement. Biochemistry 14, 4245-4251.
18. Caporale, L. H., Gaber, S. S., Kell, W., and Gotze, O. (1981) A fluorescent assay for complement activation. J. Immunol. 126, 1963-1965.
19. Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., and Allikmets, R. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38, 458-462.
20. Jonsson, G., Truedsson, L., Sturfelt, G., Oxelius, V. A., Braconier, J. H., and Sjoholm, A. G. (2005) Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine 84, 23-34. (Pubitemid 40130182)
21. Jonsson, G., Sjoholm, A. G., Truedsson, L., Bengtsson, A. A., Braconier, J. H., and Sturfelt, G. (2007) Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology 46, 1133-1139. (Pubitemid 47050617)
22. Hussain, A., Prasad, K. S., Bhattacharyya, D., and El-Bouri, K. (2007) C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl. Infection 35, 287-288. (Pubitemid 47222268)
23. Alper, C. A., Xu, J., Cosmopoulos, K., Dolinski, B., Stein, R., Uko, G., Larsen, C. E., Dubey, D. P., Densen, P., Truedsson, L., Sturfelt, G., and Sjoholm, A. G. (2003) Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J. Clin. Immunol. 23, 297-305.
24. Held, K., Thiel, S., Loos, M., and Petry, F. (2008) Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Mol. Immunol. 45, 3934-3941.
25. Ricklin, D., and Lambris, J. D. (2007) Complement-targeted therapeutics. Nat. Biotechnol. 25, 1265-1275.
26. Monk, P. N., Scola, A. M., Madala, P., and Fairlie, D. P. (2007) Function, structure and therapeutic potential of complement C5a receptors. Br. J. Pharmacol. 152, 429-448.
27. March, D. R., Proctor, L. M., Stoermer, M. J., Sbaglia, R., Abbenante, G., Reid, R. C., Woodruff, T. M., Wadi, K., Paczkowski, N., Tyndall, J. D., Taylor, S. M., and Fairlie, D. P. (2004) Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. Mol. Pharmacol. 65, 868-879.
28. Buerke, M., Schwertz, H., Seitz, W., Meyer, J., and Darius, H. (2001) Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J. Immunol. 167, 5375-5380. (Pubitemid 33009777)
29. Soulika, A. M., Holland, M. C., Sfyroera, G., Sahu, A., and Lambris, J. D. (2006) Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3. Mol. Immunol. 43, 2023-2029.
30. Inagi, R., Miyata, T., Maeda, K., Sugiyama, S., Miyama, A., and Nakashima, I. (1991) FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a. Immunol. Lett. 27, 49-52.
31. Abbenante, G., Leung, D., Bond, T., and Fairlie, D. P. (2001) An efficient Fmoc strategy for the rapid synthesis of peptide paranitroanalides. Lett. Pept. Sci. 7, 347-351.
32. Siev, D. V., and Semple, J. E. (2000) Novel hydrazino-carbonylamino- methylated polystyrene (HCAM) resin methodology for the synthesis of P1-aldehyde protease inhibitor candidates. Org. Lett. 2, 19-22.
33. Le, G. T., Abbenante, G., and Fairlie, D. P. (2007) Profiling the enzymatic properties and inhibition of human complement factor B. J. Biol. Chem. 282, 34809-34816.
34. Seelen, M. A., Roos, A., Wieslander, J., Mollnes, T. E., Sjoholm, A. G., Wurzner, R., Loos, M., Tedesco, F., Sim, R. B., Garred, P., Alexopoulos, E., Turner, M. W., and Daha, M. R. (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296, 187-198. (Pubitemid 40174752)
35. Roos, A., Bouwman, L. H., Munoz, J., Zuiverloon, T., Faber-Krol, M. C., Fallaux-van den Houten, F. C., Klar-Mohamad, N., Hack, C. E., Tilanus, M. G., and Daha, M. R. (2003) Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 39, 655-668.
36. Thielens, N. M., Villiers, C. L., Villiers, M. B., and Colomb, M. G. (1984) Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2. FEBS Lett. 165, 111-116.
37. Brown, E. J., Ramsey, J., Hammer, C. H., and Frank, M. M. (1983) Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. J. Immunol. 131, 403-408.
38. Trouw, L. A., Blom, A. M., and Gasque, P. (2008) Role of complement and complement regulators in the removal of apoptotic cells. Mol. Immunol. 45, 1199-1207.
39. Krishnan, V., Xu, Y., Macon, K., Volanakis, J. E., and Narayana, S. V. (2007) The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. J. Mol. Biol. 367, 224-233.
40. Milder, F. J., Gomes, L., Schouten, A., Janssen, B. J., Huizinga, E. G., Romijn, R. A., Hemrika, W., Roos, A., Daha, M. R., and Gros, P. (2007) Factor B structure provides insights into activation of the central protease of the complement system. Nat. Struct. Mol. Biol. 14, 224-228.
41. Jing, H., Xu, Y., Carson, M., Moore, D., Macon, K. J., Volanakis, J. E., and Narayana, S. V. (2000) New structural motifs on the chymotrypsin fold and their potential roles in complement factor B. EMBO J. 19, 164-173. (Pubitemid 30042699)
42. Robin, G., Chappell, K., Stoermer, M. J., Hu, S.-H., Young, P. R., Fairlie, D. P., and Martin, J. L. (2009) Structure of West Nile Virus NS3 Protease: Ligand stabilization of the catalytic conformation. J. Mol. Biol. 385, 1568-1577.